Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
about
The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic useNK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinomaNKG2D Ligands in Tumor Immunity: Two Sides of a CoinIL-15: a central regulator of celiac disease immunopathology.NK cell-based immunotherapy for malignant diseases.Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.Activation mechanisms of natural killer cells during influenza virus infectionInhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.Macrophages help NK cells to attack tumor cells by stimulatory NKG2D ligand but protect themselves from NK killing by inhibitory ligand Qa-1.High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent mannerIL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destructionThe natural killer cell: a further innate mediator of gouty inflammation?Human fused NKG2D-IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells.Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma.Natural killer cell lines in tumor immunotherapy.IL-15 Agonists: The Cancer Cure Cytokine.Cell transfer therapy for cancer: past, present, and future.Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia.HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathwayFunctional restoration of CD56(bright) NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B.Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis.Combining low-dose or metronomic chemotherapy with anticancer vaccines: A therapeutic opportunity for lymphomas.Supplementation with galacto-oligosaccharides increases the percentage of NK cells and reduces colitis severity in Smad3-deficient mice.IL-15 Promotes Polyfunctional NK Cell Responses to Influenza by Boosting IL-12 Production.
P2860
Q24599103-9761005B-95C8-4882-BC3A-67ADE9CB753AQ27001052-5CE2443A-1614-45F9-80B2-E1105EA43162Q28083832-CE2A17AF-7ED4-4EA3-B0F4-B76B802C28AFQ33788829-A3159366-A952-4569-B142-DAF69015B7A4Q33827433-5DD61C68-93BC-4189-B5F5-B0D3F1F853F6Q34399419-A5ACA788-5AF3-4D15-A3F0-012D8089DA65Q34540276-3ACA8C18-EBF9-4952-B863-61971D5DC433Q34766657-3D8D7FD7-671B-470A-9C0B-877EB4A32D46Q35973096-D9A0DFEE-6482-462B-952A-EBF3F3A04F1AQ36517092-A1D7A5E7-100F-456E-A730-DB9349F8DB99Q37364736-574E338D-9A63-4C41-80FE-0054B9CFF7ACQ37638179-E814CFF7-DFD7-4F1C-8C2A-5058A8E5D1B7Q37714638-3FCC6EC6-657D-4231-A20F-3A7857E76739Q37721811-FC9F3AE6-050C-4ED7-A6B1-439D30DC43F1Q37998371-1B9A4777-B55E-4F80-832A-94EFA23A4721Q38192628-BC4E78BF-6463-4A54-9BA1-074326F94BCBQ38205228-E8099582-C94C-4828-B40C-C5372908A998Q38739764-AF57F2E2-1DCF-4124-98F5-F4BFFE79C473Q39332073-6ECB1325-6890-424A-A142-38EADD0E89FCQ40150197-002BF020-81B1-4383-94C7-4CF1033609E1Q42106350-35FF8CF6-2F04-4562-922C-3B4E230C3030Q42734547-248D7FB1-9DE4-4542-BD76-890DB47B10FAQ47914100-1E4506A4-5698-47B8-B2C2-F488CC255E58Q54264715-ED6617EA-EFA5-4BC7-B047-490062BF60C9
P2860
Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Interleukin-15 improves cytoto ...... T1 and ERK1/2 phosphorylation.
@en
type
label
Interleukin-15 improves cytoto ...... T1 and ERK1/2 phosphorylation.
@en
prefLabel
Interleukin-15 improves cytoto ...... T1 and ERK1/2 phosphorylation.
@en
P2093
P1433
P1476
Interleukin-15 improves cytoto ...... T1 and ERK1/2 phosphorylation.
@en
P2093
Jiafeng Niu
Jian Zhang
Jianhua Zhang
Zhigang Tian
P304
P356
10.1016/J.CYTO.2008.01.003
P577
2008-02-15T00:00:00Z